IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity
- PMID: 20020328
- DOI: 10.1007/s11481-009-9186-y
IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity
Abstract
CD4(+) T cell subsets play an important role in the adaptive immune response in human autoimmune diseases and in animal models of autoimmunity. In recent years, our knowledge of CD4(+) T cell differentiation has increased significantly, and new subsets continue to be recognized. Of significant importance is the recent discovery of Th9 cells, the CD4 + T cell subset that produces Interleukin-9. IL-9 has largely been regarded as a Th2 cytokine; however, it is now known that under specific conditions, Tregs, Th1, Th17 and the Th9 subset of T cells also produce IL-9. The STAT family of proteins plays a major role in the signaling pathways of these CD4(+)T subsets. Biological actions of IL-9 and the STATs signaling pathways in autoimmune diseases are continuing to be clarified. Investigation of IL-9-producing CD4(+)T cells, and elucidation of the mechanisms of IL-9-induced STATs signaling, in concert with other transcription factors, will provide a better understanding of the pathogenesis of various autoimmune diseases.
Similar articles
-
Th17 cells: a third subset of CD4+ T effector cells involved in organ-specific autoimmunity.Nephrol Dial Transplant. 2008 Mar;23(3):816-9. doi: 10.1093/ndt/gfm800. Epub 2007 Nov 28. Nephrol Dial Transplant. 2008. PMID: 18045823 Review. No abstract available.
-
CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells.J Immunother Cancer. 2022 Jan;10(1):e003459. doi: 10.1136/jitc-2021-003459. J Immunother Cancer. 2022. PMID: 35091453 Free PMC article.
-
Characterization of Th9 Cells in the Development of EAE and IBD.Methods Mol Biol. 2017;1585:201-216. doi: 10.1007/978-1-4939-6877-0_16. Methods Mol Biol. 2017. PMID: 28477198
-
Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.Arch Dermatol Res. 2016 Dec;308(10):703-710. doi: 10.1007/s00403-016-1690-3. Epub 2016 Sep 29. Arch Dermatol Res. 2016. PMID: 27687555
-
Expanding the effector CD4 T-cell repertoire: the Th17 lineage.Curr Opin Immunol. 2006 Jun;18(3):349-56. doi: 10.1016/j.coi.2006.03.017. Epub 2006 Apr 17. Curr Opin Immunol. 2006. PMID: 16616472 Review.
Cited by
-
Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population.J Immunol. 2010 Oct 1;185(7):4095-100. doi: 10.4049/jimmunol.1000986. Epub 2010 Aug 30. J Immunol. 2010. PMID: 20805418 Free PMC article.
-
Exploring Advances in Natural Plant Molecules for Allergic Rhinitis Immunomodulation in Vivo and in Vitro.Int J Gen Med. 2025 Feb 1;18:529-565. doi: 10.2147/IJGM.S493021. eCollection 2025. Int J Gen Med. 2025. PMID: 39911299 Free PMC article. Review.
-
The effect of PDIA3 gene knockout on the mucosal immune function in IBS rats.Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26221224 Free PMC article.
-
The Profile of T Helper Subsets in Bone Marrow Microenvironment Is Distinct for Different Stages of Acute Myeloid Leukemia Patients and Chemotherapy Partly Ameliorates These Variations.PLoS One. 2015 Jul 2;10(7):e0131761. doi: 10.1371/journal.pone.0131761. eCollection 2015. PLoS One. 2015. PMID: 26134277 Free PMC article.
-
Effect of Th9/IL-9 on the growth of gastric cancer in nude mice.Onco Targets Ther. 2019 Mar 26;12:2225-2234. doi: 10.2147/OTT.S197816. eCollection 2019. Onco Targets Ther. 2019. PMID: 30988627 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials